U.S. federal trademark · Serial No. 85075209 · Reg. No. 552553
Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.